Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause? (Abstract)

Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?

Med Hypotheses
February 2006
https://pubmed.ncbi.nlm.nih.gov/16759815/

Inducible nitric oxide synthase is thought to be responsible for inflammatory nitric oxide concentrations in the brains of patients with MS and those with autism. It is proposed that low-dose naltrexone reduces nitric oxide synthase, thus acts as an anti-inflammatory agent.